News

Pervasive Software said that the data integration technology has allowed MedX12 to reduce new on-boarding time from several days to less than two hours. MedX12 values the accuracy,

As per the terms of the agreement, Upsher-Smith is expected to undertake the clinical development, regulatory filing and commercialisation of Tonabersat for epilepsy in the USA, Canada and

Benitec said that the Phase I study utilises a triple vector which includes one component utilising Benitec’s DNA-directed RNA interference technology, along with two other proprietary RNA technologies

PTI Inspection Systems said that VeriPac 455 technology, which is based on the ASTM vacuum decay leak test method F2338-09, was developed using VeriPac instruments. The VeriPac 455

Sunala claimed that this solvent based ink, available exclusively to the UK and Ireland pharmaceutical market, offers good finish and enhanced clarity even for small characters. The new

As per the results, EG01257, a low nanomolar potent molecule, reduced the rate of tumour growth and showed no evidence of toxicity. NRP-1 is a therapeutic target of

Omapro is used for the treatment of adults with chronic myeloid leukemia (CML) who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation. ChemGenex Pharmaceuticals

Al Dar Al Arabia was established in 2005 as a joint venture between APM, a wholly-owned subsidiary of Hikma and Dar Al Dawa. Al Dar Al Arabia owns

EDAP said that the patented electroconductive technology Sonolith i-move is a compact, stand alone lithotripter with a revolutionary infrared stereo-vision system for real-time, three-dimensional ultrasound localization of urinary